Glutamate Dynamics in Acute Ischemic Stroke

Acute ischaemic stroke arises when interruption of cerebral blood flow triggers energy failure, leading to massive release of glutamate into the extracellular space. Under normal conditions, glutamate acts as the principal excitatory neurotransmitter, but in the context of ischaemia its accumulation precipitates excitotoxicity, a process in which overactivation of NMDA and AMPA receptors induces calcium overload, oxidative stress and cell death. The brain relies on specialised transporters and enzymatic systems to clear excess glutamate, including excitatory amino acid transporters that mediate brain-to-blood efflux and enzymes such as glutamate oxaloacetate transaminase that metabolise glutamate in the circulation. When these homeostatic mechanisms are overwhelmed, the infarct core expands and the penumbral region of potentially salvageable tissue is lost. The global challenge is to restore glutamate balance quickly to minimise infarct volume and improve functional outcome. Recent advances combine molecular scavenging strategies, modulation of transporter activity and precision therapies tailored to individual blood-brain barrier status. Understanding these dynamics is critical for translating novel neuroprotective approaches into clinical practice and extending the therapeutic window for reperfusion and restorative treatments.

Research from Nature Portfolio

One study explored sustained depletion of blood glutamate by administering a long-acting bioconjugate form of human glutamate oxaloacetate transaminase in a rodent model of acute ischaemia. A single dose maintained low systemic glutamate levels for several days, resulting in reduced infarct volumes and preservation of sensorimotor function. The data support a mechanism whereby drawing glutamate out of the brain restores equilibrium between central and peripheral pools.

Another large-scale clinical investigation evaluated time-dependent variations in serum glutamate and interleukin-6 among thousands of first-ever stroke patients. High glutamate at 24 hours correlated with poorer intra-hospital recovery but paradoxically with enhanced long-term improvement, suggesting that early excitotoxic injury gives way to later restorative processes. These findings underscore the dual role of glutamate in injury and repair and highlight the need to time interventions precisely.

Glutamate Dynamics in Acute Ischemic Stroke publication trend

The graph below shows the total number of articles in glutamate dynamics in acute ischemic stroke across all publications each year (not limited to Nature Index journals).

Technical terms

Excitotoxicity: Neuronal injury and death resulting from overactivation of glutamate receptors and consequent calcium overload.

Blood–brain barrier (BBB): A selective endothelial interface that regulates exchange between the cerebral vasculature and neural tissue.

Excitatory amino acid transporters (EAATs): Membrane proteins that clear extracellular glutamate by shuttling it across cell membranes into the blood or glial cells.

Glutamate oxaloacetate transaminase (GOT): An enzyme that metabolises glutamate in blood, lowering systemic levels and promoting brain-to-blood efflux.

Penumbra: The region of hypoperfused but potentially salvageable brain tissue surrounding the infarct core.

References

1. Sustained blood glutamate scavenging enhances protection in ischemic stroke. Communications Biology (2020).
2. Intra- and extra-hospital improvement in ischemic stroke patients: influence of reperfusion therapy and molecular mechanisms. Scientific Reports (2020).
3. Remote Ischaemic Preconditioning Accelerates Brain to Blood Glutamate Efflux via EAATs-mediated Transport. Neurochemical Research (2023).
4. Glutamate Scavenging as a Neuroreparative Strategy in Ischemic Stroke. Frontiers in Pharmacology (2022).